SURFACTANT ADMINISTRATION BY SUPRAGLOTTIC AIRWAY (THE SURFSUP TRIAL)

Registry ID

SURFSUP-1

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

THE GOVERNORS OF THE UNIVERSITY OF ALBERTA

Start date

2025-11-26

Last update

2024-11-28

Conditions

• ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

Related clinical trials

• A RANDOMIZED, CONTROLLED, BLINDED, PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF AEROFACT¿ (SF-RI 1 SURFACTANT FOR INHALATION COMBINED WITH A DEDICATED DELIVERY SYSTEM) IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME
• EFFECT OF A 5-HT3 RECEPTOR ANTAGONIST ON RESPIRATORY DRIVE IN SPONTANEOUSLY BREATHING MECHANICALLY VENTILATED PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS): A PILOT PROOF-OF-CONCEPT CROSSOVER NON-RANDOMIZED CONTROLLED TRIAL
• EXTEND: NOVEL OXYGEN THERAPEUTIC NANO2 FOR MILD RESPIRATORY DISTRESS IN PHASE IB AND ARDS IN PHASE II TRIALS

View on source registry